Dr. Stephen D. Sides, D.O.
Rheumatology (Rheumatology Physician)
1241 W Stadium Blvd
Jefferson City, MO 65109
Who else practices at this address →
Cole County is a federal primary care and dental shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- At Still University of Health Sciences, College of Osteo Med, Kirksville (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 790
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: At Still University of Health Sciences, College of Osteo Med, Kirksville
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
MO license 2001001591 -
Internal Medicine Physician
MO license 2001001591
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Boone Hospital Center Columbia, MO
- Lake Regional Health System Osage Beach, MO
- Bothwell Regional Health Center Sedalia, MO
- Phelps County Regional Medical Center Rolla, MO
Medical groups
- Jefferson City Medical Group PC (119 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 790
- Services billed
- 242,382
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, vedolizumab, 1 mg | 36,900 | 18 |
| Injection, golimumab, 1 mg, for intravenous use | 34,801 | 34 |
| Injection, denosumab, 1 mg | 30,661 | 317 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,550 | 17 |
| Injection, ocrelizumab, 1 mg | 9,007 | 12 |
| Injection, infliximab, excludes biosimilar, 10 mg | 6,190 | 26 |
| Injection, rituximab, 10 mg | 3,352 | 13 |
| Insertion of needle into vein for collection of blood sample | 1,079 | 408 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 890 | 345 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 810 | 326 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydroxychloroquine Sulfate Other prescribers in Jefferson City, MO | 1,043 |
| Methotrexate (methotrexate sodium) Other prescribers in Jefferson City, MO | 937 |
| Prednisone Other prescribers in Jefferson City, MO | 844 |
| Celecoxib Other prescribers in Jefferson City, MO | 234 |
| Folic Acid Other prescribers in Jefferson City, MO | 148 |
| Leflunomide Other prescribers in Jefferson City, MO | 126 |
| Meloxicam Other prescribers in Jefferson City, MO | 122 |
| Enbrel Sureclick (etanercept) Other prescribers in Jefferson City, MO | 107 |
| Allopurinol Other prescribers in Jefferson City, MO | 103 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Jefferson City, MO | 92 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 52 payments worth $856 in total to this clinician.
| Amgen Inc. | $209 |
|---|---|
| Janssen Biotech, Inc. | $191 |
| Novo Nordisk Inc | $64.07 |
| Dexcom, Inc. | $48.48 |
| Pfizer Inc. | $45.76 |
| Merck Sharp & Dohme LLC | $39.84 |
| Xeris Pharmaceuticals, Inc. | $38.65 |
| GlaxoSmithKline, LLC. | $30.29 |
| Food and Beverage | $834 |
|---|---|
| Consulting Fee | $21.36 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Adma Biomanufacturing LLC Apr 23, 2025 | Consulting Fee | $21.36 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $11,793 in research payments for these studies, mostly to the institutions running them.
- A Study of Baricitinib in Participants With Rheumatoid Arthritis
Eli Lilly and Company · Completed · NCT04086745
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.